TP53 and breast carcinoma: C-erbB-2 expression has been linked to resistance to chemotherapy and poor outcome (Andrulis et al, 1998), while apoptosis-related proteins such as p53 and bcl-2 have been related to disease-free interval and survival of breast cancer patients (Thor et al, 1992; Gasparini et al, 1995).